ATE549309T1 - Polyisoprevonl benzophenone als inhibitoren von histonacetyltransdferasen und anwendungen dafür - Google Patents
Polyisoprevonl benzophenone als inhibitoren von histonacetyltransdferasen und anwendungen dafürInfo
- Publication number
- ATE549309T1 ATE549309T1 AT04799059T AT04799059T ATE549309T1 AT E549309 T1 ATE549309 T1 AT E549309T1 AT 04799059 T AT04799059 T AT 04799059T AT 04799059 T AT04799059 T AT 04799059T AT E549309 T1 ATE549309 T1 AT E549309T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- inhibitors
- pcaf
- histone
- mum
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 4
- 239000012965 benzophenone Substances 0.000 title abstract 3
- 108010033040 Histones Proteins 0.000 title 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 title 1
- 102100038885 Histone acetyltransferase p300 Human genes 0.000 abstract 3
- 102100022846 Histone acetyltransferase KAT2B Human genes 0.000 abstract 2
- 101001047006 Homo sapiens Histone acetyltransferase KAT2B Proteins 0.000 abstract 2
- 150000008366 benzophenones Chemical class 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 241000283690 Bos taurus Species 0.000 abstract 1
- 108010077544 Chromatin Proteins 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 abstract 1
- 241000593508 Garcinia Species 0.000 abstract 1
- 101710155878 Histone acetyltransferase p300 Proteins 0.000 abstract 1
- 101100341791 Mus musculus Kat2b gene Proteins 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 229940041181 antineoplastic drug Drugs 0.000 abstract 1
- 230000003915 cell function Effects 0.000 abstract 1
- 150000005829 chemical entities Chemical class 0.000 abstract 1
- 210000003483 chromatin Anatomy 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000000464 effect on transcription Effects 0.000 abstract 1
- 238000011156 evaluation Methods 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/78—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/687—Unsaturated compounds containing a keto groups being part of a ring containing halogen
- C07C49/697—Unsaturated compounds containing a keto groups being part of a ring containing halogen containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN929CH2003 IN2003CH00929A (enExample) | 2003-11-13 | 2003-11-13 | |
| PCT/IB2004/052294 WO2005047457A2 (en) | 2003-11-13 | 2004-11-04 | Polyisoprenyl benzophenones as inhibitors of histone acetyl transferases and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE549309T1 true ATE549309T1 (de) | 2012-03-15 |
Family
ID=34586954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04799059T ATE549309T1 (de) | 2003-11-13 | 2004-11-04 | Polyisoprevonl benzophenone als inhibitoren von histonacetyltransdferasen und anwendungen dafür |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7402706B2 (enExample) |
| EP (1) | EP1694622B1 (enExample) |
| AT (1) | ATE549309T1 (enExample) |
| IN (1) | IN2003CH00929A (enExample) |
| WO (1) | WO2005047457A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7154002B1 (en) | 2002-10-08 | 2006-12-26 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| US7250514B1 (en) | 2002-10-21 | 2007-07-31 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| US7169801B2 (en) | 2003-03-17 | 2007-01-30 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| EP1824831A2 (en) | 2004-12-16 | 2007-08-29 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| JP2008540574A (ja) | 2005-05-11 | 2008-11-20 | タケダ サン ディエゴ インコーポレイテッド | ヒストンデアセチラーゼ阻害剤 |
| US7732475B2 (en) | 2005-07-14 | 2010-06-08 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| AR057579A1 (es) * | 2005-11-23 | 2007-12-05 | Merck & Co Inc | Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac) |
| KR101005173B1 (ko) * | 2008-02-18 | 2011-01-04 | 인제대학교 산학협력단 | 항산화 및 세포독성 활성을 나타내는 물레나물과의가르시니아 오블롱기폴리아로부터 추출된 분획물 및그로부터 분리된 화합물 |
| CN102575236B (zh) * | 2009-09-07 | 2014-10-01 | 贾瓦哈拉尔尼赫鲁高级科学研究中心 | 利用ctk7a抑制组蛋白乙酰转移酶及其方法 |
| CN103459362B (zh) * | 2010-12-09 | 2015-11-25 | 英德斯生物科技私人有限公司 | 山竹醇与环糊精络合物及其方法 |
| WO2013148114A1 (en) * | 2012-03-30 | 2013-10-03 | University Of Florida Research Foundation, Inc. | P300/cbp inhibitors and methods of use |
| GB201215942D0 (en) * | 2012-09-06 | 2012-10-24 | Glaxo Group Ltd | Method of treatent |
| JP2020525425A (ja) * | 2017-06-22 | 2020-08-27 | サミ ラブズ リミテッド | 小胞体ストレスの治療管理のためのガルシノール組成物 |
| DK3681885T3 (da) | 2017-09-15 | 2024-04-15 | Forma Therapeutics Inc | Tetrahydro-imidazo-quinolinsammensætninger som cbp/p300-inhibitorer |
| AU2019295790B2 (en) | 2018-06-29 | 2023-07-13 | Forma Therapeutics, Inc. | Inhibiting creb binding protein (CBP) |
| EP3937940A4 (en) | 2019-03-15 | 2022-12-21 | Forma Therapeutics, Inc. | Inhibiting cyclic amp-responsive element-binding protein (creb) |
| US11795168B2 (en) | 2020-09-23 | 2023-10-24 | Forma Therapeutics, Inc. | Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP) |
| US11801243B2 (en) | 2020-09-23 | 2023-10-31 | Forma Therapeutics, Inc. | Bromodomain inhibitors for androgen receptor-driven cancers |
| EP4346786A4 (en) * | 2021-06-02 | 2025-07-30 | Council Of Scient And Industrial Research An Indian Registered Body Incorporated Under Regn Of Soc A | SMALL MOLECULE MODULATOR TARGETING A RARE HISTONE MODIFICATION REGULATING ADIPOGENESIS AND ASSOCIATED PHARMACEUTICAL FORMULATION |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08259493A (ja) * | 1995-03-20 | 1996-10-08 | Sugimoto Masami | 抗ｍｒｓａ活性物質 |
-
2003
- 2003-11-13 IN IN929CH2003 patent/IN2003CH00929A/en unknown
-
2004
- 2004-11-04 EP EP04799059A patent/EP1694622B1/en not_active Expired - Lifetime
- 2004-11-04 US US10/579,219 patent/US7402706B2/en not_active Expired - Fee Related
- 2004-11-04 AT AT04799059T patent/ATE549309T1/de active
- 2004-11-04 WO PCT/IB2004/052294 patent/WO2005047457A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US7402706B2 (en) | 2008-07-22 |
| US20070254961A1 (en) | 2007-11-01 |
| IN2003CH00929A (enExample) | 2008-10-06 |
| WO2005047457A3 (en) | 2005-08-04 |
| WO2005047457B1 (en) | 2005-12-01 |
| WO2005047457A2 (en) | 2005-05-26 |
| EP1694622A2 (en) | 2006-08-30 |
| EP1694622B1 (en) | 2012-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE549309T1 (de) | Polyisoprevonl benzophenone als inhibitoren von histonacetyltransdferasen und anwendungen dafür | |
| Szelest et al. | A new insight into the potential role of tryptophan-derived AhR ligands in skin physiological and pathological processes | |
| DE602004021685D1 (de) | Markierungsfreier nachweis biologischer und chemischer stoffe mittels evaneszenzfeld | |
| ATE428698T1 (de) | Die aktivität von gamma-secretase blockierende malonamidderivate | |
| ATE537155T1 (de) | Zur behandlung von diabetes, obesitas und dyslipidämie geeignete inhibitoren von 11-beta- hydroxysteroid-dehydrogenase-1 | |
| GEP20115280B (en) | Inhibitors of serine proteases | |
| BRPI0508464B8 (pt) | sulfonilpirróis, composição farmacêutica compreendendo os mesmos e uso dos mesmos | |
| DE60215652D1 (de) | Aromatische hydroxamsäurederivate, die sich als hdac inhibitoren eignen | |
| CY1113651T1 (el) | Αντιφλεγμονωδη σκευασματα | |
| NO20055316D0 (no) | Nye heterocykliske forbindelser som er nyttige ved behandling av inflammatoriske og allergiske forstyrrelser, fremgangsmate for fremstilling derav og farmasoytiske sammensetninger som inneholder slike | |
| ATE521612T1 (de) | Synthese von boronsäureester- und boronsäureverbindungen | |
| CY2014028I1 (el) | Ενωσεις, φαρμακοτεχνικες μορφες και μεθοδοι θεραπειας ή αποτροπhς ροδοχρωμης ακμης | |
| UY27993A1 (es) | Derivados de 4-pirrolidino-fenil-bencil eter | |
| CY1108932T1 (el) | Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων | |
| DE602004007693D1 (de) | (3-oxo-3,4-dihydro-chinoxalin-2-yl-amino)-benzamid-derivate und verwandte verbindungen als glykogen-phosphorylase-hemmer zur behandlung von diabetes und adipositas | |
| ATE316561T1 (de) | C-nitrosoanilinverbindungen und deren mischungen als polymerisationsinhibitoren | |
| ATE496109T1 (de) | Umsetzungsprodukte von mercaptobenzothiazolen, mercaptothiazolinen und mercaptobenzimidazolen mit epoxiden als schmiermitteladditive | |
| ATE399165T1 (de) | Chinolinverbindungen und deren verwendungen | |
| NO20055741L (no) | Nye kjemiske forbindelser | |
| SE0302304D0 (sv) | Novel compounds | |
| DE602004006118D1 (de) | 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER | |
| Ruswanto et al. | Synthesis and molecular docking of isonicotinohydrazide derivatives as anti-tuberculosis candidates | |
| EP1692263A4 (en) | COMPOSITIONS, METHODS AND DETECTION TECHNOLOGIES FOR THE REITERATIVE OLIGONUCLEOTIDE SYNTHESIS | |
| EP1879616A4 (en) | SYNTHESIS OF SUPERANTIC BODIES AND THEIR USE IN THE DETECTION, PREVENTION AND TREATMENT OF DISEASES | |
| ITSV20030016A1 (it) | Sostanze contenenti tannini o miscele di tannini. |